Inipomp

Pantoprazole, the active ingredient in Inipomp, is a proton pump inhibitor presented as an intravenous solution for intravenous use. It reduces gastric acid secretion by inhibiting the H+/K+ ATPase in parietal cells, thereby treating acid‑related conditions such as gastroesophageal reflux disease, erosive esophagitis, peptic ulcer disease, and helping to prevent NSAID‑induced gastric ulcers in hospitalized patients.

GNH USA supplies Inipomp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets European Union quality standards and is distributed under strict Good Distribution Practice guidelines.

Pantoprazole is used to manage acid‑related gastrointestinal disorders by decreasing gastric acid production.

- Gastroesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Erosive esophagitis: facilitates mucosal healing and prevents progression of ulceration. - Peptic ulcer disease: promotes ulcer healing and reduces risk of recurrence. - Prevention of NSAID‑induced gastric ulcers: protects the gastric lining in patients receiving non‑steroidal anti‑inflammatory drugs.

Pantoprazole may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild pain or pressure in the head. - Diarrhea: loose, watery stools. - Nausea: feeling of sickness or urge to vomit. - Abdominal pain: discomfort or cramping in the stomach area.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: severe diarrhea with abdominal pain and fever. - Liver enzyme elevation: signs of hepatic dysfunction such as jaundice.

When using Inipomp, consider the following precautions to ensure safe therapy.

- Assess renal and hepatic function: adjust therapy if impairment is present. - Monitor electrolytes: especially magnesium and potassium during prolonged use. - Use the lowest effective dose: limit duration to the shortest period required. - Caution in patients with known hypersensitivity to pantoprazole or other PPIs. - Avoid abrupt discontinuation: taper to reduce rebound acid hypersecretion. - Store at controlled room temperature: keep in original packaging, protect from light and moisture.

Pantoprazole can interact with several medicines; awareness of the interaction level helps guide clinical decisions.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Ketoconazole, itraconazole, and other azole antifungals: decreased absorption due to higher gastric pH. - Atazanavir and rilpivirine (HIV protease inhibitors): reduced drug exposure.

Moderate Interactions (Monitor Closely): - Warfarin: possible increased INR, monitor coagulation. - Digoxin: increased serum levels, monitor for toxicity. - Methotrexate: reduced clearance, monitor renal function and levels.